Here’s a product description for you: an accurate, non-invasive continuous glucose monitor that talks to your iPhone, and will call someone if the CGM alarms and you don’t respond. Sounds like something you might have heard about in our annual DiabetesMine Design Contest, isn’t it? Well, guess again! It’s a product actually under production by the folks at C8 MediSensors, a San Jose-based company. If you’re wondering why you’ve never heard of them, C8 MediSensors…Read more »
I’m very fortunate — and geekishly thrilled! — to be the first U.S. diabetic to review the new iBGStar, glucose meter and logging app for the iPhone and iPod Touch. Yup, it’s that meter that plugs right into an iPhone! And nope, it’s not FDA approved or available on the market in America yet.
I happen to have a longstanding relationship with the folks at AgaMatrix, the innovative company that designed iBGStar for Sanofi-Aventis. The…
Speaking of iPhone-ish diabetes devices (aren’t we always?), a number of readers asked us lately for an update on the new Tandem insulin pump, which could hardly look more Apple’esque if it tried:
The San Diego-based company has been developing this one for several years, and recently added some famous names to its Clinical Advisory Board: insulin pump experts Dr. Bruce Bode, CDEs Virginia Valentine and John Walsch, and Dr. Steven Edelman of TCOYD fame.…Read more »
Dr. Josh Makower is Co-founder of Stanford’s Biodesign Innovation Program, and a Consulting Associate Professor of Medicine at the Stanford University Medical School. He’s also Founder and Chief Executive Officer of ExploraMed, a medical device incubator. And he’s a Venture Partner with New Enterprise Associates, where he supports the investing activity in new medical devices.
In short, Dr. Makower is a world authority on med-tech innovation. I bumped into him while beginning preparations for the…
Last Wednesday, diabetes researchers and advocates from around the country convened in Washington, DC, for an FDA hearing on the Artificial Pancreas with the aim of making this pipe dream a reality. The point of the hearing was to allow JDRF and other stakeholders — researchers, industry reps, and patients — a chance to provide input on the Artificial Pancreas Project, in particular “recommendations to ensure the safe and effective testing of artificial pancreas technology…Read more »